Antiandrogen-Estrogen Therapy for Signs of Androgenization

Frontmatter -- Welcome address / Flamigni, C. -- Contents -- Introduction / Haspels, A. A. / Vange, N. van der -- Antiandrogen therapy for signs of androgenization: an overview / Schindler, A. E. -- I. Pharmacology and physiology -- Pharmacological aspects of cyproterone acetate / Neumann, F. -- Pharmacokinetics of cyproterone acetate and ethinyl estradiol in smoking and non-smoking women during treatment with Diane-35 / Zurth, Chr. / Täuber, U. -- Ovulation inhibitory effect of SH B 209 AE (Diane-35)—a new antiandrogen-estrogen combination / Spona, J. / Huber, J. / Schmidt, J. B. -- A study to investigate the maintenance of ovulation inhibition when patients switch over from Diane to Diane-35 / Higgins, H. P. / Davies, T. G. / Hutchinson, P. E. -- Effect of a new antiandrogen-estrogen sub-fifty combination on the endometrium / Fedele, L. / Marchini, M. / Carinelli, S. G. / Zamberletti, D. / Baglioni, A. -- II. Polycystic ovary syndrome -- Endocrinological and clinical findings on the therapy with Diane-35 in polycystic ovary syndrome / Falsetti, L. / Casarotti, G. A. / Gastaldi, A. -- Discussion -- III. Effects on the haemostatic system -- Longitudinal study on the effects of a cyproterone acetate and ethinyl estradiol combination on haemostasis / Bruni, V. / Bucciantini, S. / Rosati, D. / Verni, A. / Abbate, R. / Pinto, S. -- Haemorheological effects of Diane-35 and Microgynon®—Preliminary results of a double blind study / Ernst, E. / Schmölzl, Ch. / Matrai, A. / Schramm, W. -- Antiandrogen treatment in women with acne: a controlled trial / Ashton, R. E. / Miller, J. A. / Wojnarowska, F. T. / Dowd, P. M. / O’Brien, T. J. / Griffiths, W. A. D. / Jacobs, H. S. -- IV Special aspects -- Clinical assessment of two antiandrogen treatments, cyproterone acetate combined with ethinyl estradiol and spironolactone in hirsutism / Rubens, R. / Vermeulen, A. -- Treatment of severe androgenization symptoms with Diane and intramuscularly applied cyproterone acetate (Androcur Depot) / Kaiser, E. -- One-year experience with a new oral contraceptive using natural estradiol and cyproterone acetate / Hirvonen, E. / Stenman, U.-H. / Vartiainen, E. -- Discussion -- V. Metabolic and clinical aspects -- Clinical and metabolic effects of a new estrogenantiandrogen low dose combination / Cecco, L. De / Capitanio, G. L. / Bertolini, S. / Croce, S. / Centonze, A. -- Effects of cyproterone acetate on serum lipoproteins when administered alone and in combination with ethinyl estradiol / Silfverstolpe, G. / Lindberg, U.-B. / Enk, L. / Samsioe, G. / Crona, N. -- Clinical, metabolic and endocrine effects of long term use of a cyproterone acetate and ethinyl estradiol combination in hyperandrogenized women / Gaspard, U. J. / Bonnivert, J. / Emonts, P. / Gillain, D. / Lambotte, R. -- Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne : results of a multi-center study / Carlborg, L. -- Comparison of Diane-35 with Neo-Eunomin from the dermatological viewpoint / Nürnberger, F. -- A double blind comparative study of tetracycline and Diane, alone and in combination in the treatment of acne / Greenwood, R. / Brummitt, L. / Burke, B. / Cunliffe, W. J. -- The comparative efficacy and safety of Diane- 35 versus Diane-50 in the treatment of moderate to severe acne and seborrhea: preliminary results / Fugère, P. / Percival-Smith, R. K. L. / Lussier-Cacan, S. / Tétrault, C. / Farquhar, D. J. -- Results of an extended open phase m study with Diane-35 / Aydinlik, S. -- Discussion -- Closing remarks / Lachnit-Fixson, U. -- List of first-mentioned contributors